Q1 EPS Estimates for Lam Research Lifted by Zacks Research

Key Points

• Zacks Research has increased its Q1 2026 earnings per share estimate for Lam Research from $0.96 to $1.18, with a full-year estimate of $3.71 per share.
• Several analysts have upgraded their price targets for Lam Research, with Mizuho and Argus both setting the target price at $120.
• Lam Research reported strong quarterly earnings with $1.33 per share, exceeding expectations, and a significant 33.6% revenue increase year-over-year.

Lam Research Corporation (NASDAQ:LRCX - Free Report) - Zacks Research lifted their Q1 2026 earnings per share estimates for shares of Lam Research in a research report issued on Wednesday, August 20th. Zacks Research analyst Team now forecasts that the semiconductor company will earn $1.18 per share for the quarter, up from their prior estimate of $0.96. The consensus estimate for Lam Research's current full-year earnings is $3.71 per share. Zacks Research also issued estimates for Lam Research's Q2 2026 earnings at $0.99 EPS, Q3 2026 earnings at $1.03 EPS, FY2026 earnings at $4.23 EPS, Q2 2027 earnings at $1.09 EPS, Q3 2027 earnings at $1.15 EPS, Q4 2027 earnings at $1.16 EPS and FY2027 earnings at $4.52 EPS.

A number of other research firms have also recently issued reports on LRCX. Mizuho lifted their price target on Lam Research from $115.00 to $120.00 and gave the company an "outperform" rating in a report on Friday, August 1st. Argus boosted their target price on shares of Lam Research from $105.00 to $120.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Erste Group Bank assumed coverage on shares of Lam Research in a research report on Thursday, August 14th. They set a "buy" rating on the stock. Wall Street Zen raised shares of Lam Research from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Finally, TD Cowen boosted their price objective on shares of Lam Research from $100.00 to $125.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Twenty equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $107.30.

Lam Research Price Performance

Shares of Lam Research stock opened at $100.08 on Monday. The stock has a market capitalization of $126.66 billion, a price-to-earnings ratio of 24.06, a P/E/G ratio of 1.29 and a beta of 1.65. The firm's 50-day moving average price is $98.41 and its two-hundred day moving average price is $84.62. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. Lam Research has a 1-year low of $56.32 and a 1-year high of $108.02.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. During the same period in the prior year, the business posted $1.03 earnings per share. The business's revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS.

Institutional Investors Weigh In On Lam Research

Institutional investors have recently made changes to their positions in the stock. Smallwood Wealth Investment Management LLC bought a new position in Lam Research during the first quarter worth about $26,000. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the 2nd quarter valued at approximately $26,000. West Paces Advisors Inc. bought a new position in Lam Research during the 4th quarter worth approximately $27,000. Mpwm Advisory Solutions LLC bought a new position in Lam Research during the 4th quarter worth approximately $27,000. Finally, Howard Hughes Medical Institute acquired a new position in Lam Research during the second quarter valued at approximately $27,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.